SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019543
Filing Date
2016-05-16
Accepted
2016-05-16 16:16:28
Documents
47
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20160331.htm 10-Q 1587947
2 EX-10.2 aimt-ex102_214.htm EX-10.2 68371
3 EX-10.3 aimt-ex103_213.htm EX-10.3 72642
4 EX-31.1 aimt-ex311_9.htm EX-31.1 18069
5 EX-31.2 aimt-ex312_6.htm EX-31.2 18048
6 EX-32.1 aimt-ex321_8.htm EX-32.1 16987
  Complete submission text file 0001564590-16-019543.txt   5314203

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aimt-20160331.xml EX-101.INS 1205881
8 XBRL TAXONOMY EXTENSION SCHEMA aimt-20160331.xsd EX-101.SCH 26738
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20160331_cal.xml EX-101.CAL 31227
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20160331_def.xml EX-101.DEF 95922
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20160331_lab.xml EX-101.LAB 248795
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20160331_pre.xml EX-101.PRE 185122
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 161654023
SIC: 2834 Pharmaceutical Preparations